pharma · Osteoarthritis, Knee · Eosinophilic esophagitis · EPRX
EUPRAXIA PHARMACEUTICALS
EUPRAXIA PHARMACEUTICALS INC.
EUPRAXIA PHARMACEUTICALS patent portfolio — 3 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Victoria, CA
- Founded
- 2012
- Employees
- 52
- Programs
- 4
- Drugs
- 1
- Patents
- 3
EUPRAXIA PHARMACEUTICALS patents
3 pharmaceutical patents indexed for EUPRAXIA PHARMACEUTICALS. 0 expire within 24 months.
EUPRAXIA PHARMACEUTICALS has 3 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 11351124
Sustained release of formulations of local anesthetics
granted -
US 11219604
Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
granted -
US 9987233
Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
granted
Frequently asked questions
How many patents does EUPRAXIA PHARMACEUTICALS have?
3 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do EUPRAXIA PHARMACEUTICALS patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.